Back to video list Back to Home Is there a value of initiating a long-acting injectable if adherence might not be a concern? You may also like Alzheimer's Disease Article Alzheimer’s disease in 2021 & beyond – Where we are now Migraine Satellite symposium Article How to address the full impact of migraine Alzheimer's Disease Article High Mobility Group Box 1 (HMGB1) in Vascular Dementia: Mechanism, Biomarker Potential, and Therapeutic Implication Migraine Satellite symposium Article Experts’ perspectives on managing chronic migraine in their own clinical practice